Voloridge Investment Management
BLFS icon

Voloridge Investment Management’s BioLife Solutions BLFS Stock Holding History

Voloridge Investment Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,578
Closed -$278K – 1386
2023
Q2 		$278K Sell
12,578
-88,158
-88% -$1.86M ﹤0.01% 1294
2023
Q1 		$2.19M Buy
100,736
+24,080
+31% +$542K 0.01% 960
2022
Q4 		$1.4M Buy
76,656
+64,537
+533% +$1.33M 0.01% 1058
2022
Q3 		$276K Buy
+12,119
New +$259K ﹤0.01% 1332
2020
Q4 		– Sell
-13,194
Closed -$382K – 1321
2020
Q3 		$382K Buy
+13,194
New +$285K ﹤0.01% 1132

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Voloridge Investment Management's BLFS Position: Q3 2023 in Review

Voloridge Investment Management sold out of BioLife Solutions (BLFS) in Q3 2023, closing a stake of 12,578 shares — an estimated $278K sold.

Voloridge Investment Management first reported a position in BLFS in Q3 2020 and held it in 5 quarters. The position peaked at $2.19M in Q1 2023. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • Voloridge Investment Management reported no remaining BioLife Solutions position as of Q3 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 12,578 BioLife Solutions shares in Q3 2023, an estimated $278K.
  • Voloridge Investment Management first reported a position in BioLife Solutions in Q3 2020 and held it in 5 quarters.
  • Voloridge Investment Management's BioLife Solutions position peaked at $2.19M in Q1 2023.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.